Shows / Eyewire News: The Podcast

Eyewire News: The Podcast
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
6m · median of 115 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
Eyewire News: The PodcastSpecial Report: TFOS DEWS III Leaders Discuss New DED Guidance
Leaders from the Tear Film and Ocular Surface Society discuss the biggest takeaways from the recently released TFOS DEWS III report. Learn more about your ad…
Eyewire News: The PodcastFirst Commerical Surgeries Performed with MacTel Therapy
Charles Wykoff, MD, PhD, shares his experience performing the first commercial case for a patient with MacTel; VSY Biotechnology launches its Enova Hydrophobic…
Eyewire News: The PodcastAlcon Acquires Staar for $1.5 Billion
Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop…
Eyewire News: The PodcastTryptyr Now Available in US
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two…
Eyewire News: The PodcastHarrow Adds Biosimilars to US Portfolio
Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides…
Eyewire News: The PodcastAECOS Presentation Summaries
Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium. Learn more about your ad choices. Visit…
Eyewire News: The PodcastAlcon Acquires LumiThera
Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment…
Eyewire News: The PodcastGlaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational…
Eyewire News: The PodcastSpecial Report: Update on Holland Foundation
The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular…
Eyewire News: The PodcastTFOS DEWS III Published
The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in…
Eyewire News: The PodcastFirst Myopia Drug Approved in Europe
The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John…
Eyewire News: The PodcastAlcon Gains FDA Approval for Novel DED Drug
Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in…
Eyewire News: The PodcastSpecial Report: Executives Discuss Overcoming Challenges
Ophthalmology executives share challenging situations they encountered, as well as the steps needed to overcome the challenge. Learn more about your ad…
Eyewire News: The PodcastB+L Launches New Scleral Lenses Technology
B+L launches a new scleral lenses technology in the US; New World Medical introduces a transparent tip on its Streamline Surgical System, and an OCT platform…
Eyewire News: The PodcastB+L Receives Approval in Europe for LuxLife IOL
Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug…
Eyewire News: The PodcastOphthalmic Leaders Launch SightLine Meeting
Commercial stakeholders discuss the challenges and opportunities in ophthalmology in this special edition of Eyewire News: The Podcast. Learn more about your…
Eyewire News: The PodcastBreaking News from the ASCRS Meeting in Los Angeles
EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn…
Eyewire News: The PodcastFDA Issues CRL to Regeneron for Eylea HD Extended Dosing
The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent…
Eyewire News: The PodcastOrasis Launches Presbyopia Eye Drop Qlosi
A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a…
Eyewire News: The PodcastUtilizing AI to Provide DR Screening to Underserved Communities
EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye…
Eyewire News: The PodcastAlcon Launches PanOptix Pro in US
Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a…
Eyewire News: The PodcastAlcon Announces Plans to Acquire Lensar
Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch +…
Eyewire News: The PodcastFDA Expands Product Label for Iluvien
Iluvien receives a major label expansion; Bausch and Lomb launches a new orthokeratology lens fitting system; and several updates are announced in development…
Eyewire News: The PodcastFDA Approves First Treatment for MacTel
The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia…
Eyewire News: The PodcastHaag-Streit Launches METIS 900 Microscope
Haag-Streit launches the METIS 900 ophthalmic microscope system; the FDA accepts Glaukos’ NDA for Epi-on cross-linking; and Optos releases its next generation…
Eyewire News: The PodcastNew Myopia Software on Pentacam AXL
Oculus launches new myopia software on its Pentacam AXL; the first clinical polygenic risk score test for glaucoma in the US is launched; and Virtual Vision…
Eyewire News: The PodcastAlcon Voyager DSLT Fully Launched in US
Alcon launches the first DSLT device in thee US; the FDA approves an expanded label for Astellas Pharma's geographic atrophy drug Izervay; and New World…
Eyewire News: The PodcastAAO Opposes NIH Research Funding Proposal
The AAO responds to a proposal by the NIH to limit indirect funding for research projects; Lumenis launches a new device to address lower lid laxity and…
Eyewire News: The PodcastFDA Approves Genentech's Susvimo Ocular Implant for DME
The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and…
Eyewire News: The PodcastNorlase Launches First Pattern Scanning LIO
The world’s first and only pattern scanning laser indirect ophthalmoscope is approved in the US and Europe; the European Commission approves a biosimilar to…
Eyewire News: The PodcastZeiss MEL 90 Approved by FDA
Zeiss receives a major approval for its new excimer laser; Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and geographic atrophy; and Rayner…
Eyewire News: The PodcastSpecial Report – Increasing Access to Care Through the Cure Blindness Project
Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world. Learn more…
Eyewire News: The PodcastGlaukos Submits NDA for Epi-On CLX Candidate
Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and…
Eyewire News: The Podcast2024 Year in Review — Part 2
In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical…
Eyewire News: The Podcast2024 Year in Review — Part 1
In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including…
Eyewire News: The PodcastB+L Bolsters Glaucoma Offerings with Elios Acquisition
Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of…
Eyewire News: The PodcastPhase 3 Results for Novel Sedation Tablet
New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook…
Eyewire News: The PodcastPhakic IOL for Presbyopia Approved in Europe
A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel…
Eyewire News: The PodcastSpecial Report: OWL Celebrates 20th Anniversary
Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad…
Eyewire News: The PodcastLumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease…
Eyewire News: The PodcastOphthalmic Executives Provide Company Updates (Part 2 of 2)
Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of…
Eyewire News: The PodcastOphthalmic Executives Provide Company Updates (Part 1 of 2)
We hear from executives representing pharma and device manufacturers in the anterior segment who provide updates on their companies’ recently launched products…
Eyewire News: The PodcastPosterior Segment Company Updates
Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides…
Eyewire News: The PodcastBreaking News From the AAO Meeting in Chicago
Eyewire News: The Podcast reports on new products and breaking news live from the American Academy of Ophthalmology meeting in Chicago. Learn more about your…
Eyewire News: The PodcastB+L Receives FDA Approval for enVista Envy IOL
Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a…
Eyewire News: The PodcastAldeyra Resubmits NDA for DED Drug Reproxalap
Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and…
Eyewire News: The PodcastWater-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and…
Eyewire News: The PodcastTwo Partnerships Formed to Advance Glaucoma Treatments
Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy…
Eyewire News: The PodcastBreaking News From the ESCRS Congress in Barcelona (Part 2 of 2)
EyewireTV reports on new products and breaking news live from the European Society of Cataract and Refractive Surgeons Congress in Barcelona. Learn more about…
Eyewire News: The PodcastBreaking News From the ESCRS Congress in Barcelona (Part 1 of 2)
Zeiss Lenticule Extraction for Hyperopia • Alcon Ngenuity 1.5 • Oculus Pentacam Cornea OCT • Lensar ALLY Adaptive Cataract Treatment System • BVI Serenity IOLs…
Eyewire News: The PodcastWeekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell…
Eyewire News: The PodcastWeekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
Rayner Unveils First AI-Designed Spiral IOL • Visionix Launches VX 610 Non-Mydriatic Automated Fundus Camera • Injectsense Completes First Human Implant of…
Eyewire News: The PodcastWeekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics…
Eyewire News: The PodcastWeekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for…
Eyewire News: The PodcastWeekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin
Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin • Wearable Aid with AI-Powered Visual Assistant is Unveiled • ASCRS Business of Refractive…